首页 | 本学科首页   官方微博 | 高级检索  
检索        


Scleroderma Lung Disease
Authors:Jérôme Le Pavec  David Launay  Stephen C Mathai  Paul M Hassoun  Marc Humbert
Institution:1.Université Paris-Sud 11, Centre National de Référence de l’Hypertension Artérielle Pulmonaire, Service de Pneumologie et Réanimation Respiratoire, H?pital Antoine-Béclère, Assistance Publique, H?pitaux de Paris,Clamart,France;2.Division of Pulmonary and Critical Care Medicine,Baltimore,USA;3.Université Lille 2. Centre de Référence de la Sclérodermie Systémique, Service de Médecine Interne, H?pital Claude-Huriez,Lille,France
Abstract:Pulmonary involvement is second in frequency only to esophageal involvement as a visceral complication of systemic sclerosis (SSc) and has surpassed renal involvement as the most common cause of death. Interstitial lung disease and pulmonary vascular disease, particularly pulmonary arterial hypertension, are the most commonly encountered types of lung involvement. Chronic aspiration, airway disease, neuromuscular weakness, extrinsic pulmonary restrictive pathology, pleural effusions, pneumothorax, and lung cancer cause clinically significant disease and occur commonly enough to be routinely considered in the assessment of the SSc patient with respiratory symptoms. Affected patients have a significantly worse prognosis than patients with SSc who are free of pulmonary involvement.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号